| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Cas No. | |
| Concentration | |
| Form | Powder |
| Product Type | |
| Purity | |
| Reconstitution | |
| Shipping | |
| Solubility | Soluble in DMSO. Spin down all products before handling. |
| Source | Synthetic |
| Storage | |
| Target |
Product details
- Chemical name: 5-methylbenzo[g][1,3]benzoxazol-2-amine
- Also known as: 5-Methylnaphtho[2,1-d]oxazol-2-amine
- CAS number: 1820708-73-3
- Molecular formula: C12H10N2O
- Purity: >97% (HPLC)
- Concentration: 100 nM - 10 µM
- Form: Powder
- Solubility: Soluble in DMSO. Spin down all products before handling.
- Reconstitution: Soluble in DMSO. Spin down all products before handling.
- Shipping: Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
- Target: KCa3.1 channels
- Source: Synthetic
- Activity: SKA-121 is a positive gating modulator of KCa3.1 channels (EC50 of 109 nM), potent and selective over KCa2 subtypes (EC50 of 4.4-8.7 μM). Significantly lowers mean arterial blood pressure in vivo in wild-type hypertensive mice (100 mg/kg i.p.)1.
- Alternative names: 5-Methylnaphtho[2,1-d]oxazol-2-amine
Scientific background
KCa3.1 is a calcium-activated K+ channel. KCa2/3 channels are voltage-independent and share a Ca2+/calmodulin-mediated gating mechanism1.KCa3.1 and KCa2 channels are expressed in cells and enable them to hyperpolarize in order to regulate Ca2+ influx through inward rectifier Ca2+ channels, pass on hyperpolarization through gap junctions, or regulate firing frequency by preventing an untimely or premature action potential initiation2. Pharmacological activation of KCa channels has therefore been suggested as a treatment for various diseases. The different specific activities of KCa2 and KCa3.1 channels create a difference between the activators of these two types of channels. KCa2 activators can potentially reduce neuronal excitability in central nervous system disorders like epilepsy and ataxia. KCa3.1 activators could be useful as endothelial targeted antihypertensives and to enhance fluid secretion in the airways in cystic fibrosis3,4.The positive-gating modulators used until today have low selectivity and affect both KCa2 and KCa3.1, making it impossible to differentiate the phenotypes of these two receptors. To avoid KCa2 channel-mediated side effects, it is highly desirable to identify selective KCa3.1 activators that could be used as pharmacological tools to further dissect the in vivo role of KCa3.1 in blood pressure control and to help determine whether KCa3.1 activators could eventually be developed into a new class of endothelial-targeted antihypertensives. SKA-121 (5-methylnaphtho[2,1-d]oxazol-2-amine), a compound generated through an isosteric replacement approach, activates KCa3.1 with an EC50 of 111 nM, exhibits 40- to 80-fold selectivity over the three KCa2 channels and lowers blood pressure in mice as determined by telemetry without exerting KCa2 channel-mediated effects on HR5.
Lead time: 1-2 Business Days
Country of origin: Israel/IL
Applications key
Application key: FC- Flow cytometry, IFC- Indirect flow cytometry, IHC- Immunohistochemistry,LCI- Live cell imaging, Calcium imaging assay,Cell survival assay, Electrophysiology, Neurite outgrowth assay.
Bioassay tested: Yes
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).
